Page 15 - ப்ரொஃபெஸர் ஆஃப் மருந்து இல் ஹார்வர்ட் மருத்துவ பள்ளி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: 28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients with elevated cardiovascular risk Consistent reductions in overall stroke and in ischemic stroke observed across multiple subgroups Administration of pure icosapent ethyl, VASCEPA, represents a novel clinical approach to stroke reduction REDUCE-IT® STROKE abstract receives prestigious Paul Dudley White International Scholar Award to recognize the authors with the highest ranked abstract from the United States at the International Stroke Conference 2021 DUBLIN, Ireland and BRIDGEWATER, N.J., March 17, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN) today announced the presentation of REDUCE-IT® STROKE at the International Stroke Conference 2021, being held virtually from March 17 – March 19, 2021,

United statesNew jerseyUnited arab emiratesClin cardiolColl cardiolAlina kolomeyerSteven ketchumDeepakl bhattPaul dudley whiteAmerican heart associationHarvard medical schoolProfessor of medicine at harvard medical schoolExchange commissionPaul dudley white international scholar awardInternational stroke conferenceAmarin corporation